Back to DE Deerfield Management Company, L.P.
BCRX
Showing 8 of 26 quarters
Position history for DEDeerfield Management Company, L.P.'s holdings in BioCryst Pharmaceuticals, Inc.
Yes. Deerfield Management holds 15,490,928 shares of BCRX, worth $129M, as of its Q3 2026 13F filing. It increased the position by 394,525 shares (+2.6%) from Q2 2026. Deerfield Management has held BCRX since Q1 2023, across 15 quarterly 13F filings. BCRX is 2.0% of Deerfield Management's reported 13F portfolio.
Current Value
$129M
Current Shares
15.5M
Total Value Change
+$67.8M
Total Shares Change
+7.3M
Quarter-by-Quarter History